GlobeNewswire Inc | Jul 28, 2021 08:00AM EDT

July 28, 2021

CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its second quarter 2021 financial results as well as operational highlights before the open of the U.S. financial markets onWednesday, August 11, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Timeto discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date: Wednesday, August 11, 2021Time: 8:30 AM Eastern TimeUnited States: 877-407-3982International: 201-493-6780Conference ID: 13722002Webcast: http://public.viavid.com/index.php?id=146013

The conference call will be broadcast live and will be available for replay for 30 days on the Companys website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Companys website at least 10 minutes ahead of the conference call to register.

About BrainsWayBrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy. Current indications include major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Cresskill, NJ and Jerusalem, Israel, BrainsWay is committed to increasing global awareness and broad access to Deep TMS. For the latest news and information about BrainsWay, please visitwww.brainsway.com.

Contacts:BrainsWay:Scott Areglado SVP and Chief Financial Officer617-771-2287SAreglado@brainsway.com

Investors:Bob YedidLifeSci Advisors646-597-6989Bob@LifeSciAdvisors.com